Complementary Technologies and Capabilities Add Value, Drive Growth for Both Companies
PHILADELPHIA & CRANBURY, N.J.–PCI Pharma Services (PCI), a leading pharmaceutical and biopharmaceutical global outsourcing solutions provider, and Experic, a contract manufacturing organization (CMO) and pharmaceutical supply service company, are joining forces with a strategic, synergistic partnership involving clinical and commercial manufacturing, packaging and supply chain services.
The agreement will give Experic access to PCI’s clinical and commercial supply chain capabilities and strong presence in Europe. In turn, Experic will provide PCI access to advanced powder-filling equipment and capabilities including low dose filling for inhalation and other delivery modalities. This partnership will enhance the growth and success of both organizations.
“We’re extremely pleased to be working with Experic, whose expertise in dry powder inhalation and other scalable manufacturing solutions will mean added value for our clients and our future as a company,” said Salim Haffar, CEO, PCI Pharma Services. “Sharing capabilities and collaborating on services will allow our respective differentiators to complement one another, strengthening both companies, and allowing us to provide patients new and better treatments within a complex drug supply chain ecosystem.”
“This exciting partnership with PCI, a leading global outsourcing solutions provider to pharma and biopharma companies, facilitates a rapid expansion of the services we offer to clients. It’s a partnership that makes sense for both organizations – providing access to solutions that help each company expand its portfolio of offerings to clients,” said Jeff McMullen, CEO, Experic.
Under the reciprocal agreement, Experic will have access to PCI’s integrated full services in the EU, including the PCI European quality control team, providing their clients access to manufacturing, packaging, storage and delivery services that facilitate clinical trials in the region.
For PCI, Experic brings state-of-the-art manufacturing technologies and filling equipment for micro-dosing through its partnership with Germany-based Harro Höfliger. Experic’s low dose powder filling capabilities will also enable the efficient transition of products from clinical to commercial-scale manufacturing.
About PCI Pharma Services
The global healthcare industry trusts PCI for the drug development solutions that increase their products’ speed to market and opportunities for commercial success. Only PCI brings the proven experience that comes with more than 50 successful product launches a year and over five decades in the healthcare business. Leading technology and continued investment enable us to address global development needs throughout the product life cycle — from Phase I Clinical trials through commercialization and ongoing supply. Our clients view us as an extension of their business and a collaborative partner, with the shared goal of improving patients’ lives. For more information, please visit www.pciservices.com or follow us on Twitter at @PCI_Social.
Experic, a contract manufacturing organization (CMO) and pharmaceutical supply services company, supports every phase of a product’s life cycle from conception to clinical and commercial scale, across a range of dosing and packaging formats, including tablets, pellets, capsules, and low dose dry powder inhalation. From our state-of-the-art, Class A cGMP facility, we manage global delivery of the highest quality products, even for expedited projects, while providing unparalleled knowledge, expertise, and customer service. Learn more about our manufacturing and supply services at www.expericservices.com.